Have a symptom?
See what questions
a doctor would ask.
Supplements » Permixon



Permixon: Permixon is an herbal formula that is claimed to have a beneficial effect on benign prostatic hypertrophy (enlarged prostate). Permixon contains saw palmetto.

Adequate Amounts Claimed As Beneficial For Conditions: Permixon

Adequate amounts of Permixon are claimed to be potentially beneficial for:

Adequate Amounts Claimed As Preventative For Conditions: Permixon

Adequate amounts of Permixon are claimed to be potentially preventative for:

Toxicity/Overdose Risks For Supplement Or Excessive Intake: Permixon

Excessive intake of Permixon may involve the following risks:

  • Nausea
  • Vomiting
  • Abdominal pain
  • Constipation
  • Diarrhea
  • Bleeding
  • Impotence
  • Can affect PSA testing
  • Do not take if you have diseases of the stomach, liver, heart or lungs or a bleeding disorder or are on blood thinners unless under medical supervision
  • Do not use in children
  • Do not use during pregnancy or lactation
  • Interactions, possibly severe, with some other medications and supplements
  • Possible allergic reaction in some people
  • Consult with your healthcare provider before using any supplements, herbal remedies or alternative therapies

More Vitamins & Supplements Topics

  • Nutri-Joint
  • Oatstraw
  • Olbas Cough Syrup
  • Omega-3 Fatty Acids
  • Omega-6 Fatty Acids
  • Once-Per-Day Garlic
  • Oral Aloe Vera
  • Oregon Grape Root
  • PABA
  • Pantothenic acid

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise